SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001628280-22-016347
Filing Date
2022-06-06
Accepted
2022-06-06 16:24:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 9662
  Complete submission text file 0001628280-22-016347.txt   10614
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations